Paul Walsh

Paul Walsh, CA, currently serves as Senior Director of Commercial Finance at Sarepta Therapeutics since August 2020, where previous roles include Director of Commercial Finance, Director of Corporate Accounting, Associate Director of Corporate Accounting, and Senior Manager of Corporate Accounting. Prior to this, Paul Walsh held positions at The Siegfried Group as Senior Manager and Manager from January 2018 to August 2020, and at Mazars UK as Financial Accountant from May 2017 to December 2017. Earlier experience includes roles at EY as Assistant Manager and Audit Assistant Manager, as well as Group Financial Reporting Manager at Tunstall Healthcare (UK). Paul Walsh is a Chartered Accountant, having obtained this qualification from ICAS between 2010 and 2013, and holds a BA (Hons) in French & Linguistics from the University of Oxford.